Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- How was the market finally able to stage a back-to-back, two-day rally? Jim Cramer told his Mad Money viewers Monday that today's strength wasn't caused by a Warren Buffett 'halo,' nor a top in the dollar, nor a renewed interest in growth stocks. It was a combination of all three.

Put simply, when billionaire investor Warren Buffett speaks, the markets just feel better. The Oracle of Omaha preaches good, old-fashioned investing fundamentals, like doing your homework, buying stocks at the prices you want to pay and investing for the long term.

Then there's the U.S. dollar, which seems to have finally topped. That's great news for international and industrial stocks because a dollar tailwind could make all the difference for these names.

Finally, there's been a renewed interest in the high-growth stocks like the biotechs. Stocks like Cognizant Technologies (CTSH) - Get Report, Taser Int'l (TASR) and Wynn Resorts (WYNN) - Get Report were all up on the day, with others like Buffalo Wild Wings (BWLD) bouncing back from recent declines and Shake Shack (SHAK) - Get Report mounting a sizable short-squeeze that sent shares up 6.9%.

Add them together and you've got a perfect recipe for a continued rally.

Executive Decision: Andrew Liveris

For his "Executive Decision" segment, Cramer spoke with Andrew Liveris, CEO of Dow Chemical (DOW) - Get Report, a stock Cramer owns for his charitable trust, Action Alerts PLUS.

Liveris said that for Dow, productivity is "a journey, not a destination," which is why his company is continually adopting a "less is more" strategy and becoming more technology driven and focused on customers. Dow has a portfolio of products that works no matter what the price of oil, Liveris continued, something that had not historically been the case.

When asked about Europe, Liveris said the demand is there in countries like Germany and with a strong dollar, Europe's economy is finally starting to move.

Turning to the topic of chlorine, a business Dow is in the process of spinning off, Liveris said Dow started in the chlorine business but now realizes that its capital can be better invested in higher-growth areas.

For all those reasons, Cramer declared Dow the "cheapest industrial cyclical I know."

What Does Buffett Know?

What can investors glean from Warren Buffett's top four holdings, American Express (AXP) - Get Report, Coca-Cola (KO) - Get Report, IBM (IBM) - Get Report and Wells Fargo (WFC) - Get Report?

Among the four, Cramer felt only Wells Fargo, an Action Alerts PLUS name, was worth owning. He said that American Express has lost its edge to the faster-growing Visa (V) - Get Report and MasterCard (MA) - Get Report, and losing its partnership with Costco (COST) - Get Report was a big loss.

Cramer felt that Coca-Cola was intriguing, not for its business but for its investments in Keurig Green Mountain (GMCR) and Monster Beverage (MNST) - Get Report. That said, investors would be better served owning Pepsico (PEP) - Get Report.

IBM is a work in progress, but does offer a dividend while the company reinvents itself once again.

Then there's Wells Fargo, a bank that's only one interest rate hike away from sizable gains as the American economy continues to strengthen.

Executive Decision: Dr. Stanley Crooke

In his second "Executive Decision" segment, Cramer also sat down with Dr. Stanley Crooke, chairman and CEO of Isis Pharmaceuticals (ISIS) , a stock that's up over 350% since Cramer first got behind the company in October 2012. Isis currently has 38 different drugs under development.

Crooke commented on today's news that Isis has entered into a licensing deal with Bayer (BAYRY) for its expected blockbuster blood-thinning drug, currently named Factor 11, or FRXI. He said Isis explored many possible partners, but Bayer knows the space and has the experience and commitment to make FRXI the huge success they know it will be.

Crooke said that Isis will explain the deal in a lot more detail on Tuesday's earnings call.

Additionally, Crooke said that Isis will be providing updates soon on its muscular dystrophy and diabetes trials and will have more news regarding Akcea Therapeutics, its new subsidiary dedicated to the development of the next generation of lipid drugs. 

Cramer noted shares of Isis have pulled back quite a bit from their highs and with news like the Bayer deal they represent substantial value. Shares of Isis closed up 2.4% Monday.

Lightning Round

In the Lightning Round, Cramer was bullish on

Oshkosh Truck

(OSK) - Get Report


Canadian Solar

(CSIQ) - Get Report


First Solar

(FSLR) - Get Report


Southwest Airlines

(LUV) - Get Report


Cramer was bearish on Genworth Financial (GNW) - Get Report, CH Robinson Worldwide (CHRW) - Get Report, Sequenom (SQNM) and Virgin America (VA) .

Off the Tape

In his "Off the Tape" segment, Cramer sat down with Ali Partovi, Silicon Valley angel investor in and adviser to Farmland LP, a real estate investment trust helping farmers make the switch to natural and organic farming.

Partovi said there's a common misconception that organic foods are more expensive because they cost more to produce. In reality, organic foods command higher prices because there is tremendous demand and still a very limited supply.

The problem lies with the fact that farmers must stop using chemicals for a full three years before they can call their crops organic. That's why Farmland LP is providing investments to farmers to help get them through the transition.

Partovi said investors like Warren Buffett, whose portfolio is peppered with old-line, non-organic food companies, tend to stick with what they know and are missing the bigger trend towards natural and healthy foods, which is increasing by the day.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in DOW, MA and WFC.